Across this body of literature the compound has been described under several names: pentadecapeptide BPC-157, the full Body Protection Compound 157, the early trial designation PL 14736, and the proprietary name Bepecin used in early Croatian pharmaceutical work
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium
Q: What is the difference between BB10, BB20, and BB30
Higher doses mean higher residual levels at any given time point, which means the excess from early injection is proportionally larger
It is essential for anyone who wants brighter, healthier skin and a more even complexion
Our intention in seeking additional information is not to privilege once source over the other